Evidence map›Paper›PMID 30285809›Full record

ArticleBreast cancer research : BCR2018

Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.

Hui Zhang, Tricia Fredericks, Gaofeng Xiong, Yifei Qi, Piotr G Rychahou, Jia-Da Li, Taina Pihlajaniemi, Wei Xu, Ren Xu

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. The Multifaced Role of Collagen in Cancer Development and Progression.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Article
  16. Targeting KCell death discovery · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hui ZhangDepartment of Laboratory Medicine, The First Hospital of Jilin University, Changchun, 130021, Jilin Province, China.
Tricia FredericksDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, 40504, USA.
Gaofeng XiongUK Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
Yifei QiUK Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
Piotr G RychahouDepartment of Surgery, College of Medicine, University of Kentucky, Lexington, KY, 40504, USA.
Jia-Da LiCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410078, Hunan Province, China.
Taina PihlajaniemiCenter for Cell-Matrix Research and Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, 90014, Oulu, Finland.
Wei XuDepartment of Laboratory Medicine, The First Hospital of Jilin University, Changchun, 130021, Jilin Province, China. xu_w@jlu.edu.cn.
Ren XuUK Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA. ren.xu2010@uky.edu.ORCID 0000-0002-3591-9522
University of Kentucky · USCentral South University · CNJilin University · CNUniversity of Oulu · FI

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Roles of Hsp47 in Breast Cancer ProgressionR01CA207772 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI XU, REN · 2017 to 2025
$3.1M
Roles of RORalpha in breast cancer development and progressionR01CA215095 · NCI · UNIVERSITY OF KENTUCKY · PI XU, REN · 2017 to 2022
$1.7M
Systemic delivery of miR-29 for basal-like breast cancer treatmentR21CA209045 · NCI · UNIVERSITY OF KENTUCKY · PI SHU, DAN, XU, REN · 2016 to 2017
$375k
NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA207772NCI NIH HHS R01 CA215095NCI NIH HHS R21 CA209045
6 · The paper itself

Abstract

backgroundIncreased collagen expression and deposition are associated with cancer progression and poor prognosis in breast cancer patients. However, function and regulation of membrane-associated collagen in breast cancer have not been determined. Collagen XIII is a type II transmembrane protein within the collagen superfamily. Experiments in tissue culture and knockout mouse models show that collagen XIII is involved in cell adhesion and differentiation of certain cell types. In the present study, we determined roles of collagen XIII in breast cancer progression and metastasis.

methodsWe analyzed the association of collagen XIII expression with breast cancer development and metastasis using published gene expression profiles generated from human breast cancer tissues. Utilizing gain- and loss- of function approaches and 3D culture assays, we investigated roles of collagen XIII in regulating invasive tumor growth. Using the tumorsphere/mammosphere formation assay and the detachment cell culture assay, we determined whether collagen XIII enhances cancer cell stemness and induces anoikis resistance. We also inhibited collagen XIII signaling with β1 integrin function-blocking antibody. Finally, using the lung colonization assay and the orthotopic mammary tumor model, we investigated roles of collagen XIII in regulating breast cancer colonization and metastasis. Cox proportional hazard (log-rank) test, two-sided Student's t-test (two groups) and one-way ANOVA (three or more groups) analyses were used in this study.

resultsCollagen XIII expression is significantly higher in human breast cancer tissue compared with normal mammary gland. Increased collagen XIII mRNA levels in breast cancer tissue correlated with short distant recurrence free survival. We showed that collagen XIII expression promoted invasive tumor growth in 3D culture, enhanced cancer cell stemness, and induced anoikis resistance. Collagen XIII expression induced β1 integrin activation. Blocking β1 integrin activation significantly reduced collagen XIII-induced invasion and mammosphere formation. Importantly, silencing collagen XIII in MDA-MB-231 cells reduced lung colonization and metastasis.

conclusionsOur results demonstrate a novel function of collagen XIII in promoting cancer metastasis, cell invasion, and anoikis resistance.

Indexed as

AnoikisAnimalsBreast NeoplasmsCell LineCell Line, TumorCollagen Type VIIIFemaleHumansLung NeoplasmsMembrane ProteinsMice, SCIDRNA InterferenceRNAi TherapeuticsSurvival AnalysisXenograft Model Antitumor AssaysCollagen Type VIIIMembrane ProteinsCell anoikisExtracellular matrixMembrane-associated collagenMetastasisStemness

Identifiers

PMID30285809
PMCPMC6167877
OpenAlexW2893877178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.